Differential Complete Blood Count for Diagnosis of COVID-19?

Table 2.

Comparison ofPast Medical History between Case and Control Groups.

Variable Case Group Control Group Total X2 Value P Value (Sig)

Gender Male 47 (54%) 36 (41.9%) 83 (48.0%) 2.563 0.109
(NS)
Female 40 (46%) 50 (58.1%) 90 (52.0%)

CND +ve 51 (58.6%) 48 (55.8%) 99 (57.2%) 0.139 0.709
(NS)
+ve 51 (58.6%) 48 (55.8%) 99 (57.2%)

DM -ve 48 (55.2%) 49 (57.0%) 97 (56.1%) 0.057 0.811
(NS)
+ve 39 (44.8%) 37 (43.0%) 76 (43.9%)

HTN -ve 58 (66.7%) 51 (59.3%) 109 (63.0%) 1.006 0.316
(NS)
+ve 29 (33.3%) 35 (40.7%) 64 (37.0%)

IHD -ve 82 (94.3%) 81 (94.2%) 163 (94.2%) 0.000 0.985
(NS)
+ve 5 (5.7%) 5 (5.8%) 10 (5.8%)

Stroke -ve 78 (89.7%) 83 (96.5%) 161 (93.1%) 0.132 0.076
(NS)
+ve 9 (10.3%) 3 (3.5%) 12 (6.9%)

Heart Failure -ve 83 (95.4%) 80 (93.0%) 163 (94.2%) 0.449 0.503
(NS)
+ve 4 (4.6%) 6 (7.0%) 10 (5.8%)

Anemia -ve 87 (100%) 81 (94.2%) 168 (97.1%) 5.209 0.022
(Sig)
+ve 0 (0%) 5 (5.8%) 5 (2.9%)

NS: Non-Significant Sig: Significant.